BARCELONA – Barcelona’s biotech and pharmaceutical companies seeking specialized preclinical contract research organization (CRO) services can accelerate their drug discovery timelines with Anilocus. We provide comprehensive preclinical research support specifically designed for Barcelona’s dynamic life sciences ecosystem, delivering the regulatory expertise and scientific precision your projects demand.
Supporting Europe’s Premier BioRegion Capital
Barcelona stands as Europe’s leading biotech hub within the BioRegion of Catalonia, hosting over 1,500 life sciences companies and 93 health research entities that contribute 7.6% to the region’s GDP. The ecosystem encompasses 17 of the world’s top 20 pharmaceutical and medical technology firms, while Barcelona ranks 5th in Europe and 8th globally for active clinical trials. In 2024, Barcelona’s biotech startups and scaleups raised a record €347 million, with 75% coming from international investors, establishing the city as Europe’s second-best place to invest in biotech.
The city hosts major pharmaceutical companies including AstraZeneca, Sanofi, Novartis, Almirall, and Grifols, alongside innovative biotech companies like Aelix Therapeutics, Minoryx Therapeutics, Ona Therapeutics, Oryzon Genomics, and Highlight Therapeutics developing breakthrough therapies in oncology, rare diseases, and dermatology. Barcelona’s proximity to world-class research institutions including IRB Barcelona, Centre for Genomic Regulation (CRG), Barcelona Science Park, and EMBL Barcelona creates an unparalleled environment for collaborative drug discovery and development.
Barcelona’s strategic position as Europe’s biotech capital and Spain’s established regulatory framework provide unique advantages for companies targeting EMA approval, with streamlined access to both European and international markets. This established pharmaceutical cluster requires specialized CRO services to support the complex preclinical studies necessary for EMA, FDA, and global regulatory approval.
Why Barcelona Biotech Companies Choose Anilocus
- European regulatory expertise and EMA knowledge – Deep understanding of EMA requirements and international compliance standards, leveraging Barcelona’s position as Europe’s premier biotech hub for comprehensive regulatory navigation across multiple jurisdictions
- Specialized in vivo capabilities – Advanced in vivo assessments and custom study designs that complement Barcelona’s strength in oncology, rare disease research, and antibody-drug conjugate innovation across diverse therapeutic areas
- Integrated preclinical solutions – Comprehensive study design through regulatory submission support, reducing vendor management complexity and accelerating development timelines for Barcelona biotech companies
Preclinical CRO Services
Anilocus delivers the full spectrum of preclinical research services that Barcelona’s pharmaceutical industry demands. Our capabilities span multiple critical areas of drug development, from initial compound characterization through regulatory submission support.
Pharmacodynamics
Our pharmacodynamics studies determine the biochemical and physiological effects of compounds through receptor binding assays, enzyme inhibition assays, signal transduction assays, functional cell-based assays, and biomarker analysis. These investigations reveal how drug candidates interact with their molecular targets and produce therapeutic effects.
Pharmacokinetics
Pharmacokinetics research characterizes absorption, distribution, metabolism, and excretion properties using plasma concentration-time profiling, bioavailability assays, microsomal stability assays, permeability (Caco-2) assays, and blood-brain barrier penetration assays. This data is essential for understanding drug exposure and designing optimal dosing regimens.
Toxicology
Our toxicology studies assess potential adverse effects through acute toxicity assays, sub-chronic toxicity assays, chronic toxicity assays, maximum tolerated dose (MTD) assays, and no observed adverse effect level (NOAEL) determination. These comprehensive evaluations establish safe dose ranges and identify target organs of toxicity.
Safety Pharmacology
Safety pharmacology investigations examine effects on vital physiological systems using hERG channel inhibition assays, ECG telemetry assays, respiratory rate monitoring, locomotor activity assays, and core body temperature assays. This ensures drug candidates don’t adversely affect cardiovascular, respiratory, or central nervous system function.
Bioanalytics Testing for Barcelona Biotech
Genotoxicity
Our genotoxicity studies evaluate genetic damage potential through Ames tests, in vitro micronucleus assays, chromosomal aberration assays, comet assays, and mouse lymphoma assays. These investigations are crucial for identifying compounds that might cause cancer or heritable defects.
Reprotox
Reproductive and developmental toxicology assessments examine drug impact on fertility and development using fertility and early embryonic development assays, embryo-fetal development assays, prenatal and postnatal development assays, teratogenicity assays, and sperm morphology assays. These studies ensure reproductive safety across generations.
Immunotoxicity
Our immunotoxicology services detect immune system effects through T-cell proliferation assays, natural killer cell activity assays, delayed-type hypersensitivity assays, hemagglutination titer assays, and cytokine release assays. This identifies potential immunosuppression, hypersensitivity, or autoimmunity risks.
Carcinogenicity
For compounds intended for chronic use, our carcinogenicity studies assess long-term tumor formation potential using rodent bioassays (2-year studies), initiation-promotion assays, transgenic mouse models (e.g., rasH2), cell transformation assays, and DNA adduct formation assays.
Ready to Accelerate Your Barcelona Biotech Research?
Ready to advance your preclinical research with a CRO partner that understands Barcelona’s pharmaceutical ecosystem and regulatory landscape? From IRB Barcelona spinouts to established pharmaceutical companies in the Eixample district, Anilocus delivers the scientific excellence that forward-thinking Barcelona biotech companies demand.
Get Started Today!
Transform your research vision into actionable data with Anilocus, where scientific precision meets custom fabrication capability for real research impact. Contact us today and speak to a scientist about your Barcelona biotech project!
